Gastrointestinal (GI) conditions are common in neonates and infants. These may include Gastroesophageal Reflux (GER), ...

Experiments in three therapeutic cancer vaccine mouse models, conducted by investigators at the Vaccine Branch of the National Cancer Institute in Bethesda, Maryland, support the conclusion that ...

Results, presented at ObesityWeek® 2025, showed patients receiving NG101 saw 40% reduction in nausea incidence and 67% ...

Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...

Researchers at Okayama University of Science have discovered that bitter taste receptors—the same type found on the human ...

A research team from the Department of Bioscience, Faculty of Life Sciences, Okayama University of Science, has made a discovery: bitter taste receptors are present inside cancer cells and play a ...

Even though nearly all women—approximately 85%—report experiencing menopause symptoms, science has offered very few solutions ...

Sparsentan therapy was associated with sustained decline in proteinuria and lower likelihood of progression to kidney failure ...

Type 1 diabetes with CKD is understudied with no advancement of therapy options since the 1990s. The FINE-ONE phase 3 trial addresses a high, unmet need for treatments.

New phase 3 data show meaningful improvement in antibody-negative myasthenia gravis, for which treatment options are limited ...

Insilico announced the launch of its innovative cardiometabolic disease portfolio of unique highly-differentiated molecules ...